The clinical implications of MMP-11 and CK-20 expression in human breast cancer

Clinica Chimica Acta

Volumn 411, Issue 3-4, 2010, Pages 234-241

  Cheng, Chun Wen ^a,b,c   Yu, Jyh Cherng ^d   Wang, Hsiao Wei ^b   Huang, Chiun Sheng ^e   Shieh, Jia Ching ^a   Fu, Yi Ping ^f   Chang, Chia Wei ^a   Wu, Pei Ei ^b   Shen, Chen Yang ^b,g  

^a CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^b INSTITUTE OF BIOMEDICAL SCIENCES   (Taiwan)

^c CHUNG SHAN MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^d TRI SERVICE GENERAL HOSPITAL   (Taiwan)

^e NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^f UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

^g CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Breast cancer; CK 20; Lymph node metastasis; MMP 11; qRT PCR

Indexed keywords

CYTOKERATIN 20; ESTROGEN RECEPTOR; MESSENGER RNA; PROGESTERONE RECEPTOR; STROMELYSIN 3;

ADULT; AGE; AGED; ARTICLE; BREAST CANCER; CANCER STAGING; CELL SPREADING; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; FAMILY HISTORY; FEMALE; GENE EXPRESSION; GENETIC EPIGENESIS; HOMEOSTASIS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RISK FACTOR; TRANSCRIPTION REGULATION; TUMOR VOLUME;

ADULT; AGED; ANTIBODIES; BREAST NEOPLASMS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENETIC PREDISPOSITION TO DISEASE; HUMANS; IMMUNOHISTOCHEMISTRY; KERATIN-20; LYMPHATIC METASTASIS; MATRIX METALLOPROTEINASE 11; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; RNA, MESSENGER; TUMOR MARKERS, BIOLOGICAL;

EID: 72449192625     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2009.11.009     Document Type: Article

References (43)

1. Bosserhoff A.K. Novel biomarkers in malignant melanoma. Clin Chim Acta 367 (2006) 28-35
2. Wang Y., Klijn J.G., Zhang Y., et al. Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer. Lancet 365 (2005) 671-679
3. Pei D., and Weiss S.J. Furin-dependent intracellular activation of the human stromelysin-3 zymogen. Nature 375 (1995) 244-247
4. Okada A., Saez S., Misumi Y., and Basset P. Rat stromelysin 3: cDNA cloning from healing skin wound, activation by furin and expression in rat tissues. Gene 185 (1997) 187-193
5. Rio M.C. From a unique cell to metastasis is a long way to go: clues to stromelysin-3 participation. Biochimie 87 (2005) 299-306
6. Selvey S., Haupt L.M., Thompson E.W., Matthaei K.I., Irving M.G., and Griffiths L.R. Stimulation of MMP-11 (stromelysin-3) expression in mouse fibroblasts by cytokines, collagen and co-culture with human breast cancer cell lines. BMC cancer 4 (2004) 40
7. Delebecq T.J., Porte H., Zerimech F., et al. Overexpression level of stromelysin 3 is related to the lymph node involvement in non-small cell lung cancer. Clin Cancer Res 6 (2000) 1086-1092
8. Mueller J., Brebeck B., Schmalfeldt B., Kuhn W., Graeff H., and Hofler H. Stromelysin-3 expression in invasive ovarian carcinomas and tumours of low malignant potential. Virchows Arch 437 (2000) 618-624
9. Munck-Wikland E., Heselmeyer K., Lindholm J., Kuylenstierna R., Auer G., and Engel G. Stromelysin-3 mRNA expression in dysplasias and invasive epithelial cancer of the larynx. Int J Oncol 12 (1998) 859-864
10. Stojic J., Hagemann C., Haas S., et al. Expression of matrix metalloproteinases MMP-1, MMP-11 and MMP-19 is correlated with the WHO-grading of human malignant gliomas. Neurosci Res 60 (2008) 40-49
11. Moll R., Franke W.W., Schiller D.L., Geiger B., and Krepler R. The catalog of human cytokeratins: patterns of expression in normal epithelia, tumors and cultured cells. Cell 31 (1982) 11-24
12. Miettinen M. Keratin 20: immunohistochemical marker for gastrointestinal, urothelial, and Merkel cell carcinomas. Mod Pathol 8 (1995) 384-388
13. Moll R., Zimbelmann R., Goldschmidt M.D., et al. The human gene encoding cytokeratin 20 and its expression during fetal development and in gastrointestinal carcinomas. Differentiation 53 (1993) 75-93
14. Moll R., Lowe A., Laufer J., and Franke W.W. Cytokeratin 20 in human carcinomas. A new histodiagnostic marker detected by monoclonal antibodies. Am J Pathol 140 (1992) 427-447
15. Orimo A., Gupta P.B., Sgroi D.C., et al. Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through increased SDF-1/CXCL12 secretion. Cell 121 (2005) 335-348
16. Tlsty T.D. Stromal cells can contribute oncogenic signals. Semin Cancer Biol 11 (2001) 97-104
17. Zangani D., Darcy K.M., Masso-Welch P.A., Bellamy E.S., Desole M.S., and Ip M.M. Multiple differentiation pathways of rat mammary stromal cells in vitro: acquisition of a fibroblast, adipocyte or endothelial phenotype is dependent on hormonal and extracellular matrix stimulation. Differentiation 64 (1999) 91-101
18. Cheng C.W., Yu J.C., Huang C.S., et al. Polymorphism of cytosolic serine hydroxymethyltransferase, estrogen and breast cancer risk among Chinese women in Taiwan. Breast Cancer Res Treat 111 (2008) 145-155
19. Cheng T.C., Chen S.T., Huang C.S., et al. Breast cancer risk associated with genotype polymorphism of the catechol estrogen-metabolizing genes: a multigenic study on cancer susceptibility. Int J Cancer 113 (2005) 345-353
20. Yu J.C., Ding S.L., Chang C.H., et al. Genetic susceptibility to the development and progression of breast cancer associated with polymorphism of cell cycle and ubiquitin ligase genes. Carcinogenesis 30 (2009) 1562-1570
21. Pfaffl M.W. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 29 (2001) e45
22. Ananth C.V., and Kleinbaum D.G. Regression models for ordinal responses: a review of methods and applications. Int J Epidemiol 26 (1997) 1323-1333
23. Agnantis N.J., Goussia A.C., Batistatou A., and Stefanou D. Tumor markers in cancer patients. an update of their prognostic significance. Part II. In vivo 18 (2004) 481-488
24. Schedin P., and Elias A. Multistep tumorigenesis and the microenvironment. Breast Cancer Res 6 (2004) 93-101
25. Delany A.M., and Canalis E. The metastasis-associated metalloproteinase stromelysin-3 is induced by transforming growth factor-beta in osteoblasts and fibroblasts. Endocrinol 142 (2001) 1561-1566
26. Kim J.H., Kim T.H., Jang J.W., Jang Y.J., Lee K.H., and Lee S.T. Analysis of matrix metalloproteinase mRNAs expressed in hepatocellular carcinoma cell lines. Mol Cells 12 (2001) 32-40
27. Soni S., Mathur M., Shukla N.K., Deo S.V., and Ralhan R. Stromelysin-3 expression is an early event in human oral tumorigenesis. Int J Cancer 107 (2003) 309-316
28. Vazquez-Ortiz G., Pina-Sanchez P., Vazquez K., et al. Overexpression of cathepsin F, matrix metalloproteinases 11 and 12 in cervical cancer. BMC Cancer 5 (2005) 68
29. Masson R., Lefebvre O., Noel A., et al. In vivo evidence that the stromelysin-3 metalloproteinase contributes in a paracrine manner to epithelial cell malignancy. J Cell Biol 140 (1998) 1535-1541
30. Duffy M.J., Maguire T.M., Hill A., McDermott E., and O'Higgins N. Metalloproteinases: role in breast carcinogenesis, invasion and metastasis. Breast Cancer Res 2 (2000) 252-257
31. Christoph F., Muller M., Schostak M., Soong R., Tabiti K., and Miller K. Quantitative detection of cytokeratin 20 mRNA expression in bladder carcinoma by real-time reverse transcriptase-polymerase chain reaction. Urol 64 (2004) 157-161
32. Soeth E., Grigoleit U., Moellmann B., et al. Detection of tumor cell dissemination in pancreatic ductal carcinoma patients by CK 20 RT-PCR indicates poor survival. J Cancer Res Clin Oncol 131 (2005) 669-676
33. Giribaldi G., Procida S., Ulliers D., et al. Specific detection of cytokeratin 20-positive cells in blood of colorectal and breast cancer patients by a high sensitivity real-time reverse transcriptase-polymerase chain reaction method. J Mol Diagnostics 8 (2006) 105-112
34. Bae J.W., Choi K.H., Kim H.G., and Park S.H. The detection of circulating breast cancer cells in peripheral blood by reverse transcriptase-polymerase chain reaction. J Korean Med Sci 15 (2000) 194-198
35. Chausovsky G., Luchansky M., Figer A., et al. Expression of cytokeratin 20 in the blood of patients with disseminated carcinoma of the pancreas, colon, stomach, and lung. Cancer 86 (1999) 2398-2405
36. Basset P., Bellocq J.P., Lefebvre O., et al. Stromelysin-3: a paradigm for stroma-derived factors implicated in carcinoma progression. Crit Rev Oncol Hematol 26 (1997) 43-53
37. Conzen S.D. Minireview: nuclear receptors and breast cancer. Mol Endocrinol 22 (2008) 2215-2228
38. Studebaker A.W., Storci G., Werbeck J.L., et al. Fibroblasts isolated from common sites of breast cancer metastasis enhance cancer cell growth rates and invasiveness in an interleukin-6-dependent manner. Cancer Res 68 (2008) 9087-9095
39. Hegedus L., Cho H., Xie X., and Eliceiri G.L. Additional MDA-MB-231 breast cancer cell matrix metalloproteinases promote invasiveness. J Cell Physiol 216 (2008) 480-485
40. Obokata A., Watanabe J., Nishimura Y., Arai T., Kawaguchi M., and Kuramoto H. Significance of matrix metalloproteinase-7 [correction of matrix metalloproteinase-2], -11 and tissue inhibitor of metalloproteinase-1 expression in normal, hyperplastic and neoplastic endometrium. Anticancer Res 27 (2007) 95-105
41. Arora S., Kaur J., Sharma C., et al. Stromelysin 3, Ets-1, and vascular endothelial growth factor expression in oral precancerous and cancerous lesions: correlation with microvessel density, progression, and prognosis. Clin Cancer Res 11 (2005) 2272-2284
42. Bostick P.J., Chatterjee S., Chi D.D., et al. Limitations of specific reverse-transcriptase polymerase chain reaction markers in the detection of metastases in the lymph nodes and blood of breast cancer patients. J Clin Oncol 16 (1998) 2632-2640
43. Kim J., Bae J.W., Lee J.B., Son G.S., and Koo B.H. RT-PCR amplification of CK 20 mRNA in the peripheral blood of breast cancer patients: correlation with established prognostic parameters. Biomed Pharmacother 59 Suppl 2 (2005) S380-S383